Pillstats
Rx only · Tablet, Film Coated · Oral

Rivaroxaban

Brands: Xarelto · Rivaroxaban

17 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US37 NDCs
17 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers17 labelers
Packages97
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 26 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.65$5.30$7.95$10.60Dec 2025Mar 2026Jun 2026
$9.042
Latest avg · Jun 17, 2026
-1%
Since Dec 17, 2025
17
Active US suppliers
51%
Top-2 supplier share*

Who makes it17 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown32SUPPLYING
Janssen Pharmaceuticals, Inc.unknown17SUPPLYING
Indoco Remedies Limitedunknown13SUPPLYING
A-S Medication Solutionsunknown5SUPPLYING
Novadoz Pharmaceuticals LLCunknown4SUPPLYING
Changzhou Pharmaceutical Factoryunknown3SUPPLYING
Macleods Pharmaceuticals Limitedunknown3SUPPLYING
Cardinal Health 107, LLCunknown3SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING
Camber Pharmaceuticals, Inc.unknown2SUPPLYING
Exelan Pharmaceuticals, Inc.unknown2SUPPLYING
Lupin Pharmaceuticals,Inc.unknown2SUPPLYING
XLCare Pharmaceuticals Inc.unknown2SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown2SUPPLYING
NorthStar RxLLCunknown2SUPPLYING

+ 2 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.